Robert J Romanelli1, Hsiao-Ching Huang2, Sylvia Sudat3, Alice R Pressman3, Kristen M J Azar3. 1. Palo Alto Medical Foundation Research Institute, Center for Health Systems Research, Sutter Health, Palo Alto, California. Electronic address: romanerj1@sutterhealth.org. 2. Palo Alto Medical Foundation Research Institute, Center for Health Systems Research, Sutter Health, Palo Alto, California. 3. Division of Research, Development and Dissemination, Center for Health Systems Research, Sutter Health, Walnut Creek, California.
Abstract
INTRODUCTION: Translational lifestyle change programs for community and clinical settings have been available for a decade, yet there are limited data on their comparative effectiveness. This study examines the effectiveness of a Centers for Disease Control and Prevention-aligned lifestyle change program relative to usual care in clinical practice. METHODS: This was an electronic health record-based retrospective cohort study conducted in a community-based healthcare system. Investigators identified adult program participants and usual-care patients in the electronic health record between 2010 and 2018 and defined their index date (baseline) as the first lifestyle change program encounter or a random encounter date, respectively. Participants were matched 1:2 to usual-care patients on baseline demographics and clinical characteristics using propensity-score methods. Changes in body weight and blood pressure were examined from baseline through 24 months. RESULTS: The authors identified 2,833 program participants and 438,432 usual-care patients meeting study eligibility criteria. A total of 2,833 program participants were matched to 4,776 usual-care patients; the average age was 54 years, and 80% of the participants were female. Program participation was associated with a 1.9- and 1.6-fold higher prevalence of clinically meaningful (≥5%) weight loss at 12- and 24-month follow-up than usual care and a higher prevalence of blood pressure control at 12 months but not at 24 months. Patients without type 2 diabetes at baseline had more pronounced outcomes than those with type 2 diabetes. CONCLUSIONS: This study demonstrates the effectiveness of an evidence-based, Centers for Disease Control and Prevention-aligned lifestyle change program in reducing cardiometabolic risk factors compared with usual care in clinical practice, with long-term reductions in weight and transient reductions in blood pressure.
INTRODUCTION: Translational lifestyle change programs for community and clinical settings have been available for a decade, yet there are limited data on their comparative effectiveness. This study examines the effectiveness of a Centers for Disease Control and Prevention-aligned lifestyle change program relative to usual care in clinical practice. METHODS: This was an electronic health record-based retrospective cohort study conducted in a community-based healthcare system. Investigators identified adult program participants and usual-care patients in the electronic health record between 2010 and 2018 and defined their index date (baseline) as the first lifestyle change program encounter or a random encounter date, respectively. Participants were matched 1:2 to usual-care patients on baseline demographics and clinical characteristics using propensity-score methods. Changes in body weight and blood pressure were examined from baseline through 24 months. RESULTS: The authors identified 2,833 program participants and 438,432 usual-care patients meeting study eligibility criteria. A total of 2,833 program participants were matched to 4,776 usual-care patients; the average age was 54 years, and 80% of the participants were female. Program participation was associated with a 1.9- and 1.6-fold higher prevalence of clinically meaningful (≥5%) weight loss at 12- and 24-month follow-up than usual care and a higher prevalence of blood pressure control at 12 months but not at 24 months. Patients without type 2 diabetes at baseline had more pronounced outcomes than those with type 2 diabetes. CONCLUSIONS: This study demonstrates the effectiveness of an evidence-based, Centers for Disease Control and Prevention-aligned lifestyle change program in reducing cardiometabolic risk factors compared with usual care in clinical practice, with long-term reductions in weight and transient reductions in blood pressure.
Authors: Deborah A Greenwood; M Kaye Kramer; Andrea I Hankins; Carol A Parise; Amy Fox; Kimberly A Buss Journal: Diabetes Educ Date: 2014-02-21 Impact factor: 2.140
Authors: Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright Journal: Hypertension Date: 2017-11-13 Impact factor: 10.190
Authors: Ira S Ockene; Trinidad L Tellez; Milagros C Rosal; George W Reed; John Mordes; Philip A Merriam; Barbara C Olendzki; Garry Handelman; Robert Nicolosi; Yunsheng Ma Journal: Am J Public Health Date: 2011-12-15 Impact factor: 9.308
Authors: William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan Journal: N Engl J Med Date: 2002-02-07 Impact factor: 91.245
Authors: Kimberly D Brunisholz; Elizabeth A Joy; Mia Hashibe; Lisa H Gren; Lucy A Savitz; Sharon Hamilton; Wayne Cannon; Kelly Huynh; Tonya A N Schafer; Laurel M Newman; Jodi Parker; Joilynne Musselman; Jaewhan Kim Journal: J Healthc Qual Date: 2017 Sep/Oct Impact factor: 1.095
Authors: Heejung Bang; Alison M Edwards; Andrew S Bomback; Christie M Ballantyne; David Brillon; Mark A Callahan; Steven M Teutsch; Alvin I Mushlin; Lisa M Kern Journal: Ann Intern Med Date: 2009-12-01 Impact factor: 25.391
Authors: Karl K Vanderwood; Taryn O Hall; Todd S Harwell; Marcene K Butcher; Steven D Helgerson Journal: Diabetes Care Date: 2010-08-30 Impact factor: 19.112
Authors: Elizabeth K Ely; Stephanie M Gruss; Elizabeth T Luman; Edward W Gregg; Mohammed K Ali; Kunthea Nhim; Deborah B Rolka; Ann L Albright Journal: Diabetes Care Date: 2017-05-12 Impact factor: 19.112